Obstructive Sleep Apnea Syndrome Induced by Testosterone Administration

Robert E. Sandblom, Alvin M. Matsumoto, Robert Blair Schoene, Kathryn A. Lee, Elizabeth C. Giblin, William J. Bremner, David J. Pierson

Research output: Contribution to journalArticle

134 Scopus citations

Abstract

The obstructive sleep apnea syndrome is a recently described clinical disorder that results from repetitive episodes of upper-airway occlusion during sleep.1 Since the syndrome occurs much more frequently in males than females,2 it is reasonable to postulate that androgens may be important in its cause. We describe below a man in whom both the symptoms and laboratory features of the obstructive sleep apnea syndrome developed on two separate occasions in association with the administration of exogenous testosterone. The symptoms and findings remitted each time that testosterone was discontinued. These observations suggest that testosterone has a causal role in the sleep.

Original languageEnglish (US)
Pages (from-to)508-510
Number of pages3
JournalNew England Journal of Medicine
Volume308
Issue number9
DOIs
StatePublished - Mar 3 1983

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Obstructive Sleep Apnea Syndrome Induced by Testosterone Administration'. Together they form a unique fingerprint.

  • Cite this

    Sandblom, R. E., Matsumoto, A. M., Schoene, R. B., Lee, K. A., Giblin, E. C., Bremner, W. J., & Pierson, D. J. (1983). Obstructive Sleep Apnea Syndrome Induced by Testosterone Administration. New England Journal of Medicine, 308(9), 508-510. https://doi.org/10.1056/NEJM198303033080908